Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III
- 399 Downloads
Higher prevalence of nonalcoholic fatty liver disease (NAFLD) in men and postmenopausal women than in premenopausal women has suggested a potential role of sex hormones in the pathogenesis of the disease. We sought to evaluate the association between oral contraceptive pills (OCP) and NAFLD and to determine whether adiposity mediates any effect.
We included 4338 women aged 20–60 years who were enrolled in the Third National Health and Nutrition Examination Survey from 1988 to 1994 in a population-based cross-sectional study. We defined NAFLD as moderate–severe steatosis on ultrasonography in women without excessive alcohol use or other identifiable causes. OCP use was based on self-report and was categorized as never, former or current use.
The overall weighted prevalence of NAFLD was 11.6 % but lower in current (6.7 %) than in former (12.0 %) or never users (15.6 %, P = 0.016). In the multivariable model, current OCP users experienced a 50 % lower odds of NAFLD than never users (adjusted odds ratio 0.50; 95 % confidence interval 0.26, 0.98) after adjusting for age, race/ethnicity, smoking status, history of diabetes or hypertension and education. Further adjustment for body mass index or waist circumference significantly attenuated the OCP–NAFLD relationship.
In this large US-representative population, OCP use was associated with reduced odds of NAFLD. However, this association could be mediated or confounded by adiposity. Prospective studies are needed to further clarify the causal role of sex hormone.
KeywordsAdiposity Nonalcoholic fatty liver disease Obesity Oral contraceptive pill Sex hormone
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Bjoerkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution. Int J Obes. 1996;20:213–9.Google Scholar
- 12.Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M. The association of dehydroepiandrosterone, obesity, waist–hip ratio and insulin resistance with fatty liver in postmenopausal women—a hyperinsulinemic euglycemic insulin clamp study. Hepatogastroenterology. 2003;50:771–4.PubMedGoogle Scholar
- 16.National Center for Health Statistics. NHANES III data files, documentation and codebooks; 2011. http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed 16 Nov 2012.
- 19.Centers for Disease Control and Prevention. Alcohol and Public Health. Frequently asked questions: what is a standard drink in the United States? 2012. http://www.cdc.gov/alcohol/faqs.htm#standDrink. Accessed 16 Nov 2012.
- 20.National Center for Health Statistics. Third National Health and Nutrition Survey: hepatic steatosis assessment procedure manual. 2010. http://www.cdc.gov/nchs/data/nhanes/nhanes3/Hepatic_Steatosis_Ultrasound_Procedures_Manual.pdf. Accessed on 16 Nov 2012.
- 21.Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.PubMedCrossRefGoogle Scholar
- 25.StataCorp. Stata Statistical Software: release 11. College Station: StataCorp LP; 2009.Google Scholar
- 26.Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2011;(9). doi: 10.1002/14651858.CD003987.pub4.
- 34.Lacasa D, Le Liepvre X, Ferre P, Dugail I. Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression. Potential mechanism for the lipogenic effect of progesterone in adipose tissue. J Biol Chem. 2001;276:11512–6.PubMedCrossRefGoogle Scholar